These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10856546)

  • 1. Effect of immunosuppressive therapy on DNA repair and cancer incidence in renal transplant recipients.
    Weinstein T; Korzets A; Chagnac A; Ori Y; Herman M; Zevin D; Malachi T; Gafter U
    Transplant Proc; 2000 Jun; 32(4):694-5. PubMed ID: 10856546
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful conversion from cyclosporine to azathioprine in elective renal transplant recipients.
    Chuang FR; Hsieh H; Hsu KT; Chien YS; Chung HM
    Transplant Proc; 1998 Nov; 30(7):3094-6. PubMed ID: 9838365
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective CellCept therapy in high-risk renal transplant recipients.
    Isenberg A; Singh TP; Shen GK; Freed BM; Conti DJ
    Transplant Proc; 1998 Jun; 30(4):1188-9. PubMed ID: 9636480
    [No Abstract]   [Full Text] [Related]  

  • 4. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract]   [Full Text] [Related]  

  • 5. Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine.
    Ponticelli C; Yussim A; Cambi V; Legendre C; Rizzo G; Salvadori M; Kahn D; Kashi SH; Salmela K; Fricke L; Garcia-Martinez J; Lechler R; Heemann U; Monteon F; Ortuño J; Amenabar JJ; Arias M; Nicholson ML; Sperschneider H; Abendroth D; Gracida C; Lao M; Sever MS; Lameire N; Sanchez-Fructuoso A; Bascì A; Segoloni G; Connolly J; Altieri P; Akoh J; Prestele H; Girault D
    Transplant Proc; 2001; 33(1-2):1009-10. PubMed ID: 11267167
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
    Fabrega AJ; Corwin CL; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1562-3. PubMed ID: 9636634
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 11. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
    Tsai MK; Lee PH; Hu RH; Lee CJ
    Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrocytosis in renal transplant recipients.
    Hussain Z; Hashmi A; Ather H; Mohsin R; Hussain M; Naqvi A; Rizvi A
    Transplant Proc; 1995 Oct; 27(5):2736. PubMed ID: 7482896
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperamylasemia in kidney transplant recipients.
    Yokoyama I; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
    Transplant Proc; 1996 Jun; 28(3):1476-7. PubMed ID: 8658748
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
    Pascual J; Crespo M; Mateos ML; Marcén R; Orofino L; Burgos FJ; Liaño F; Ortuño J
    Transplant Proc; 1998 Jun; 30(4):1329-30. PubMed ID: 9636540
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
    Crespo JF; Górriz JL; Sancho A; Avila A; Alcoy E; Pallardó LM
    Transplant Proc; 1999 Sep; 31(6):2261-2. PubMed ID: 10500568
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression protocols for HLA identical renal transplant recipients.
    Keitel E; Santos AF; Alves MA; Neto JP; Schaefer PG; Bittar AE; Goldani JC; Pozza R; Bruno RM; See D; Garcia CD; Garcia VD
    Transplant Proc; 2003 May; 35(3):1074-5. PubMed ID: 12947863
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients.
    Abouna GM; al Arrayed AS; Farid E; Awad CK; Sharqawi SA; Tantawi M
    Transplant Proc; 1998 Dec; 30(8):4077-8. PubMed ID: 9865302
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract]   [Full Text] [Related]  

  • 20. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
    Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P
    Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.